Eisai
4523.T
#1945
Rank
โ‚น734.49 B
Marketcap
โ‚น2,606
Share price
0.09%
Change (1 day)
-34.07%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): โ‚น179.60

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น188.90. In 2022 the company made an earnings per share (EPS) of โ‚น138.67 a decrease over its 2021 EPS that were of โ‚น615.66.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น179.6029.51%
2022โ‚น138.67-77.48%
2021โ‚น615.66-41.88%
2020โ‚น1,059-0.94%
2019โ‚น1,06952.59%
2018โ‚น700.76124.17%
2017โ‚น312.60-49.42%
2016โ‚น618.0937.08%
2015โ‚น450.91-11.75%
2014โ‚น510.92-3.23%
2013โ‚น527.98-18.56%
2012โ‚น648.33-15.51%
2011โ‚น767.38-3.75%
2010โ‚น797.32-1.36%
2009โ‚น808.30